RAB Capital plc - Rule 8.3- Lombard Medical

* Reuters is not responsible for the content in this press release.

Tue Jan 15, 2008 9:08am EST

RNS Number:8197L
RAB Capital plc
15 January 2008



*LATE TRADE BOOKING*                                                 FORM 8.3


    DEALINGS BY PERSONS WITH INTERESTS IN SECURITIES REPRESENTING 1% OR MORE
                        (Rule 8.3 of the Takeover Code)


1. KEY INFORMATION

Name of person dealing (Note 1)       RAB Capital plc

Company dealt in                      Lombard Medical Technologies Plc

Class of relevant security to which   Ordinary Shares
the dealings being disclosed relate
(Note 2)

Date of dealing                       20 December 2007


2. INTERESTS, SHORT POSITIONS AND RIGHTS TO SUBSCRIBE


(a) Interests and short positions (following dealing) in the class of relevant
security dealt in (Note 3)

                             Long                        Short
                             Number        (%)           Number        (%)

(1) Relevant securities      9,541,928     (11.96%)

(2) Derivatives (other than
options)

(3) Options and agreements
to purchase/sell

Total                        9,541,928     (11.96%)


(b) Interests and short positions in relevant securities of the company, other
than the class dealt in (Note 3)

Class of relevant security:     Long                      Short
                                Number       (%)          Number       (%)

(1) Relevant securities

(2) Derivatives (other than
options)

(3) Options and agreements to
purchase/sell

Total


(c) Rights to subscribe (Note 3)

Class of relevant        Details
security:



3. DEALINGS (Note 4)


(a) Purchases and sales

Purchase/sale       Number of         Price per unit (Note 5)
                    securities

Purchase            3,571,428         GBP 0.14










(b) Derivatives transactions (other than options)

Product name, e.g.  Long/short    Number of securities   Price per unit 
CFD                 (Note 6)      (Note 7)               (Note 5)





(c) Options transactions in respect of existing securities


(i) Writing, selling, purchasing or varying

Product     Writing,    Number of   Exercise Type, e.g.  Expiry date Option
name,e.g.   selling,    securities  price    American,               money paid/
call option purchasing, to which             European                received
            varying     the option           etc.                    per unit
            etc.        relates                                      (Note 5)
                        (Note 7)



(ii) Exercising

Product name, e.g. call      Number of securities        Exercise price per unit
option                                                   (Note 5)



(d) Other dealings (including new securities) (Note 4)

Nature of transaction    Details         Price per unit (if applicable) (Note 5)
(Note 8)



4. OTHER INFORMATION


Agreements, arrangements or understandings relating to options or derivatives


Full details of any agreement, arrangement or understanding between the person
disclosing and any other person relating to the voting rights of any relevant
securities under any option referred to on this form or relating to the voting
rights or future acquisition or disposal of any relevant securities to which any
derivative referred to on this form is referenced. If none, this should be
stated.


None..................................................................


..............................................................................


Is a Supplemental Form 8 attached? (Note 9) NO



Date of disclosure                  15 January 2008

Contact name                        Kiran Patel

Telephone number                    0207 389 0968


If a connected EFM, name of offeree N/A
/offeror with which connected

If a connected EFM, state nature of N/A
connection (Note 10)

Notes

The Notes on Form 8.3 can be viewed on the Takeover Panel's website at
www.thetakeoverpanel.org.uk



                      This information is provided by RNS
            The company news service from the London Stock Exchange

END
RETBAMITMMMBBJP
Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.